EUCTR2012-004231-24-AT进行中（未招募）1 期
ong-term immunity after primary vaccination against tick-borne encephalitis in the elderly
Department für Virologie, Medizinische Universität Wien0 个研究点开始时间: 2013年2月15日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Volunteers that have received 3-dose primary TBE vaccination in the primary study 3 years ago.
- •TBE-vaccination criteria fulfilled.
- •Participants of the primary study who have received 3-dose primary TBE vaccination but did not participate in the follow-up analysis will also be included.
- •All participants have to understand and sign informed consent form (based on the judgement of the study physician)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 21
排除标准
- •Contraindication to TBE vaccination (according to SmPC 2007)
- •Immunodeficiency, history of autoimmune disease or current intake of immunomodulating drugs (corticosteroids)
研究者
相似试验
进行中（未招募）
不适用
A study to find out in the long run if the medicine called IC51 (IXIARO®, JESPECT®) is safe and works well to help children and young people not to get Japanese Encephalitis.JE can be fatal or lead to long-term disability. Vaccination should therefore be considered for people who are at risk of exposure to JEV by travelling to endemic regions. The study within which no IMP will be administered, will benefit the pediatric population as it will provide information on potential need of booster doses of IC51 in children and adolescents.MedDRA version: 17.0Level: LLTClassification code 10023123Term: Japanese encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.0Level: LLTClassification code 10023120Term: Japanese B viral encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.0Level: LLTClassification code 10023122Term: Japanese B virus encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.0Level: LLTClassification code 10023119Term: Japanese B encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.0Level: PTClassification code 10014596Term: Encephalitis Japanese BSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-022266-27-DEValneva Austria GmbH80
已完成
不适用
ong-term immunity after Yellow fever vaccinatioYellow feverJPRN-UMIN000040526Tokyo Medical University Hospital Travellers' Medical Center50
招募中
不适用
Immunity against vaccine-preventable diseases in the homeless population in GermanyMumpsB15B18A36A35B05B26B06Acute hepatitis AChronic viral hepatitisOther tetanusMeaslesRubella [German measles]DiphtheriaDRKS00016336Klinik für Allgemeine Innere Medizin, Gastroenterologie, Hepatologie, Infektiologie und PneumologieKatharinenhospital Stuttgart/Klinikum Stuttgart500
进行中（未招募）
不适用
Persistence of antibodies at 3, 4 and 6 years of age after vaccination with meningococcal, pneumococcal and Hib vaccinesHealthy volunteers (prevention of invasive diseases caused by Haemophilus influenzae (type b) and Neisseria meningitidis serogroup C)MedDRA version: 14.1Level: LLTClassification code 10027275Term: Meningococcal infection, unspecifiedSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: PTClassification code 10069533Term: Haemophilus influenzae type b immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2008-007846-69-DEGlaxoSmithKline Biologicals581
尚未招募
不适用
Evaluation of safety, effectiveness and duration of immunity after vaccination against Covid-19 in patients with autoimmune rheumatic diseasesspondylitisautoimmune diseasessystemic lupus erythematosussystemic sclerodermavasculitisSjögren's syndromerheumatoid arthritismyositisRBR-108fyykdniversidade Federal de São Paulo